Kane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel Family
13 août 2024 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and up to...